{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:58:28Z","timestamp":1785355108669,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,7]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Severe lymphocytopenia, febrile granulocytopenia, and leukopenia induced by methimazole (MMI) are extremely rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 26-year-old Han Chinese female with hyperthyroidism was admitted to the hospital with fever and tonsillar enlargement after taking MMI tablets for 1 month. Adverse drug reactions correlation analysis revealed this as a novel severe adverse reaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The patient was diagnosed with agranulocytosis with fever, thyroid storm, acute suppurative tonsillitis, and mild anemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>After admission, MMI tablets were discontinued. The patient received granulocyte colony-stimulating factor, Leucogen tablets, Diyu Shengbai tablets to elevate white blood cell count, methylprednisolone sodium succinate for inflammation, and cefuroxime sodium for infection control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient was discharged after 11 days of clinical treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Through the assessment of adverse drug reactions correlation and analysis of susceptibility factors, we recognized the importance of medication education and demonstrated that changes in clinical practice can save lives.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045322","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:01:24Z","timestamp":1762538484000},"page":"e45322","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Severe lymphocytopenia induced by methimazole tablets: A rare case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4763-0811","authenticated-orcid":false,"given":"Yi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Pengzhou Hospital of Traditional Chinese Medicine, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6470-3748","authenticated-orcid":false,"given":"Bo","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pengzhou People\u2019s Hospital, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0369-8906","authenticated-orcid":false,"given":"Liutao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/fcp.12991","article-title":"Comparison of agranulocytosis and anti-neutrophil cytoplasmic antibody-associated vasculitis caused by two antithyroid drugs: a pharmacovigilance study using the WHO international database.","volume":"38","author":"Han","year":"2024","journal-title":"Fundam Clin Pharmacol"},{"key":"R2-20260729","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/scd.12771","article-title":"Generalized gingival necrosis in a patient under methimazole use.","volume":"43","author":"Gomes","year":"2023","journal-title":"Spec Care Dentist"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"886451","DOI":"10.3389\/fendo.2022.886451","article-title":"Add-on effect of selenium and vitamin D combined supplementa tion in early control of Graves\u2019disease hyperthyroidism during methim azole treatment.","volume":"13","author":"Gallo","year":"2022","journal-title":"Front Endocrinol"},{"key":"R4-20260729","first-page":"401","article-title":"Guidelines for the diagnosis and management of hyperthyroidism and other causes of Thyrotoxicosis in China.","volume":"42","year":"2022","journal-title":"Chin J Endocrinol Metab"},{"key":"R5-20260729","first-page":"e48264","article-title":"Antithyroid drug-induced agranulocytosis: a case report.","volume":"15","author":"MacKay","year":"2023","journal-title":"Cureus"},{"key":"R6-20260729","doi-asserted-by":"crossref","first-page":"1431686","DOI":"10.3389\/fimmu.2024.1431686","article-title":"Effect of methimazole treatment on Th1, Th17, and Th22 lymphocytes in pediatric Graves\u2019 disease patients.","volume":"15","author":"Starosz","year":"2024","journal-title":"Front Immunol"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R8-20260729","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1038\/s41598-017-12350-2","article-title":"Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China.","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"R9-20260729","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/bcp.13989","article-title":"Associations of HLA genotypes with antithyroid drug-induced agranulocytosis: a systematic review and meta-analysis of pharmacogenomics studies.","volume":"85","author":"Chen","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"R10-20260729","doi-asserted-by":"crossref","first-page":"490","DOI":"10.7326\/0003-4819-124-5-199603010-00005","article-title":"Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease.","volume":"124","author":"Tamai","year":"1996","journal-title":"Ann Intern Med"},{"key":"R11-20260729","first-page":"82","article-title":"Two cases of methimazole-induced agranulocytosis with their risk factors.","volume":"8","author":"Khine","year":"2022","journal-title":"AACE Clin Case Rep"},{"key":"R12-20260729","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2013-2569","article-title":"Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.","volume":"98","author":"Nakamura","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20260729","doi-asserted-by":"crossref","first-page":"101387","DOI":"10.1016\/j.beem.2020.101387","article-title":"Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses.","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R14-20260729","doi-asserted-by":"crossref","first-page":"27","DOI":"10.11604\/pamj.2016.23.27.8365","article-title":"Antithyroid drug induced a granulocytosis: what still we need to learn?","volume":"23","author":"Chaudhry","year":"2016","journal-title":"Pan Afr Med J"},{"key":"R15-20260729","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40801-016-0091-4","article-title":"Idiosyncratic drug-induced severe neutropenia and agranulocytosis in elderly patients (\u226575 years): a monocentric cohort study of 61 cases.","volume":"3","author":"Mourot-Cottet","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"R16-20260729","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism.","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"R17-20260729","first-page":"1252","article-title":"Adverse reactions of methimazole in children with hyperthyroidism.","volume":"24","author":"Zhou","year":"2022","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R18-20260729","first-page":"311","article-title":"Clinical discussion on methimazole in the treatment of hyperthyroidism.","volume":"103","author":"Mao","year":"2023","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R19-20260729","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4158\/EP.8.3.222","article-title":"Methimazole-induced hepatotoxicity.","volume":"8","author":"Woeber","year":"2002","journal-title":"Endocr Pract"},{"key":"R20-20260729","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1507\/endocrj.K05-068","article-title":"The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves\u2019 disease.","volume":"54","author":"Tsuboi","year":"2007","journal-title":"Endocr J"},{"key":"R21-20260729","first-page":"515","article-title":"Guidelines for rational drug use at the primary level for hyperthyroidism.","volume":"20","year":"2021","journal-title":"Chin J General Pract"},{"key":"R22-20260729","doi-asserted-by":"crossref","first-page":"1705740","DOI":"10.1155\/2022\/1705740","article-title":"Benefits of long-term continuation of low-dose methimazole therapy in the prevention of recurrent hyperthyroidism in Graves\u2019 hyperthyroid patients: a randomized prospective controlled study.","volume":"2022","author":"Lertwattanarak","year":"2022","journal-title":"Int J Endocrinol"},{"key":"R23-20260729","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.etap.2013.09.015","article-title":"Efficacy and safety of methimazole ointment for patients with hyperthyroidism.","volume":"36","author":"Wu","year":"2013","journal-title":"Environ Toxicol Pharmacol"},{"key":"R24-20260729","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.etap.2013.09.015","article-title":"Efficacy and safety of methimazole ointment for patients with hyperthyroidism.","volume":"36","author":"Wu","year":"2013","journal-title":"Environ Toxicol Pharmacol"},{"key":"R25-20260729","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2004.02135.x","article-title":"Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.","volume":"61","author":"Pearce","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R26-20260729","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1345\/aph.1G422","article-title":"Effect of Graves\u2019 disease and methimazole on warfarin anticoagulation.","volume":"40","author":"Busenbark","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R27-20260729","first-page":"156","article-title":"The evaluation and management of methimazole-induced agranulocytosis in the pediatric patient: a case report and review of the literature.","volume":"98","author":"Fredette","year":"2025","journal-title":"Horm Res Paediatr"},{"key":"R28-20260729","first-page":"285","article-title":"A case of methimazole-induced taste disorder combined with leukopenia.","volume":"31","author":"Gong","year":"2022","journal-title":"Chin J Pharmacoepidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:02:01Z","timestamp":1785351721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":28,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045322","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"2025-04-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}